nirmatrelvir + ritonavir

all catalysts(0)

nothing on the calendar yet

News(8)

• Telemedicine company offers GLP-1s for addiction
  A CDC Covid restructuring, public trust in Fauci, and more health news from Morning Rounds
  stat · 24d ago
• An administrative gap delays access to new pancreatic cancer treatment
  A new wave of illegal fruity vapes, more and more kids on GLP-1s, and other health news from Morning Rounds
  stat · 25d ago
• Disabled workers at greater risk of losing health insurance
  An organ transplant first, new details on ADA conference controversy, and more health news from Morning Rounds
  stat · 29d ago
• HHS flip-flops on disability lawsuit
  Drug overdose deaths decreasing, a path to patients for AI devices, and more health news from Morning Rounds
  stat · 1mo ago
• HHS spins a tale of a would-be content creator child
  The next DSM and the algorithm, an unexpected discovery on alpha-gal syndrome, and more health news from Morning Rounds
  stat · 1mo ago
• Paxlovid did not help long Covid, study finds
  New Trump drug pricing deals, weed edibles and driving research, and more health news from Morning Rounds
  stat · 1mo ago
• Earnings roundup: Gilead’s ‘uncertain’ future, Pfizer’s crossroads and Merck’s PCSK9 launch
  Some analysts see warning signs in crucial drug launches from Gilead and Merck, while an important trial readout could change Pfizer’s growth trajectory.
  biopharma_dive · 1mo ago
• Opinion: It’s time to treat pandemics as threats to national security
  “Pandemics should be viewed and combated as threats to national security,” write David Blumenthal and James A. Morone.
  stat · 2mo ago